The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Plasma Levels of Asymmetric Dimethylarginine in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy
Abstract
Background: Asymmetric dimethylarginine (ADMA) is a marker of endothelial dysfunction and a new independent risk factor for adverse cerebrovascular events in small vessel disease. Conversely, L-arginine (LARG) may have a protective role. Methods: To assess ADMA, LARG levels and LARG/ADMA ratio in 16 patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and normal controls, and to look for possible correlations with white matter changes. Plasma levels of ADMA and LARG were assayed by high-performance liquid chromatography in all subjects. The overall T 1 and T 2 lesion load was obtained from brain MRI of patients with CADASIL. Results: ADMA plasma concentrations (1.5 ± 2.0 µ M) were significantly higher (p < 0.05) in CADASIL patients than in controls (0.35 ± 0.075 µ M). Analyzing only CADASIL subjects, an inverse borderline-significant correlation was found between LARG/ADMA (190 ± 20) and T 2-weighted lesion volumes (57.9 ± 46.5; r = –0.578, p = 0.024). Conclusion: Our results may indicate the possible coexistence of endothelial dysfunction in CADASIL patients, broadening the range of potentially pathogenetic mechanisms in this disease and providing insights for future therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“White matter lesions and lacunar strokes are associated with increases in circulating levels of the NO synthase inhibitor asymmetric dimethylarginine (ADMA) (Notsu et al., 2009; Pikula et al., 2009; Rufa et al., 2008).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Rufa et al., 2008
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Teerlink, T., Nijveldt, R. J., de Jong, S., & van Leeuwen, P. A. M. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5575 · Cited by 417
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Mechanisms of homocysteine‐induced atherothrombosis
LENTZ, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01364.x · Cited by 363
Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction
Hassan, A. (2004) · Brain · doi:10.1093/brain/awh023 · Cited by 338
Tran, C. T. L., Leiper, J. M., & Vallance, P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 314
van Waesberghe, J. H., van Walderveen, M. A. A., Castelijns, J. A., Scheltens, P., Nijeholt, G. J. L. À., Polman, C. H., & Barkhof, F. (1998) · American Journal of Neuroradiology · Cited by 311
ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans
Kielstein, J. T., Donnerstag, F., Gasper, S., Menne, J., Kielstein, A., Martens-Lobenhoffer, J., Scalera, F., Cooke, J. P., Fliser, D., & Bode-Böger, S. M. (2006) · Stroke · doi:10.1161/01.str.0000231640.32543.11 · Cited by 217
The influence of genetic and cardiovascular risk factors on the CADASIL phenotype
Singhal, S. (2004) · Brain · doi:10.1093/brain/awh223 · Cited by 217
CADASIL: A Monogenic Condition Causing Stroke and Subcortical Vascular Dementia
Dichgans, M. (2002) · Cerebrovascular Diseases · doi:10.1159/000049148 · Cited by 130
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
Wanby, P., Teerlink, T., Brudin, L. H., Brattström, L. E., Nilsson, I., Palmqvist, P., & Carlsson, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.033 · Cited by 107
Endothelial changes in muscle and skin biopsies in patients with CADASIL
Ruchoux, & Maurage (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00087.x · Cited by 101
Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy
Dubroca, C., Lacombe, P. M., Domenga, V., Maciazek, J., Levy, B. I., Tournier‐Lasserve, E., Joutel, A., & Henrion, D. (2004) · Stroke · doi:10.1161/01.str.0000149949.92854.45 · Cited by 99
Dayoub, H., Rodionov, R. N., Lynch, C. M., Cooke, J. P., Arning, E., Bottiglieri, T., Lentz, S. R., & Faraci, F. M. (2007) · Stroke · doi:10.1161/strokeaha.107.490631 · Cited by 83
Asymmetric Dimethylarginine in Cerebral Small Vessel Disease
Khan, U., Hassan, A., Vallance, P. J., & Markus, H. S. (2007) · Stroke · doi:10.1161/01.str.0000254500.27412.ac · Cited by 58
Impaired Endothelial Function of Forearm Resistance Arteries in CADASIL Patients
Stenborg, A., Kalimo, H., Viitanen, M. H., Terént, A., & Lind, L. (2007) · Stroke · doi:10.1161/strokeaha.107.490029 · Cited by 57
L-Arginine-Mediated Vasoreactivity in Patients with a Risk of Stroke
Zimmermann, C., Wimmer, M. L. J., & Haberl, R. L. (2003) · Cerebrovascular Diseases · doi:10.1159/000075781 · Cited by 48
Characteristic Features of in vivo Skin Microvascular Reactivity in CADASIL
Gobron, C., Vahedi, K., Vicaut, É., Stücker, O., Laemmel, E., Baudry, N., Bousser, M., & Chabriat, H. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600356 · Cited by 38
Zsuga, J., Török, J., Magyar, M. T., Valikovics, A., Gesztelyi, R., Kéki, S., Csiba, L., Zsuga, M., & Bereczki, D. (2007) · Cerebrovascular Diseases · doi:10.1159/000101461 · Cited by 26
Neuromuscular Implications in CADASIL
Finsterer, J. (2007) · Cerebrovascular Diseases · doi:10.1159/000108428 · Cited by 16
Research works printed but not linked: 1
- 10.1111%2Fj.1365-2990.1997.tb01210.x · doi:10.1111/j.1365-2990.1997.tb01210.x
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“White matter lesions and lacunar strokes are associated with increases in circulating levels of the NO synthase inhibitor asymmetric dimethylarginine (ADMA) (Notsu et al., 2009; Pikula et al., 2009; Rufa et al., 2008).”
Cuadrado-Godia, E., Dwivedi, P., Sharma, S., Ois Santiago, A., Roquer Gonzalez, J., Balcells, M., Laird, J., Turk, M., Suri, H. S., Nicolaides, A., et al. (2018) · Journal of Stroke · doi:10.5853/jos.2017.02922 · Cited by 286
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review
Poggesi, A., Pasi, M., Pescini, F., Pantoni, L., & Inzitari, D. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.116 · Cited by 253
Molecular biomarkers for vascular cognitive impairment and dementia
Hosoki, S., Hansra, G. K., Jayasena, T., Poljak, A., Mather, K. A., Catts, V. S., Rust, R., Sagare, A. P., Kovacic, J. C., Brodtmann, A. G., et al. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00884-1 · Cited by 184
Stevenson, S. F., Doubal, F. N., Shuler, K., & Wardlaw, J. M. (2010) · Stroke · doi:10.1161/strokeaha.109.569855 · Cited by 112
Metadata
- Authors
- Rufa, A., Blardi, P., De Lalla, A., Cevenini, G., De Stefano, N., Zicari, E., Auteri, A., Federico, A., & Dotti, M. T.
- Affiliations
- University of Siena (IT)
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 26
- Issue
- 6
- Pages
- 636-640
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W1994769231
- Cited by
- 31
- References
- 21
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 5 · 2013: 2 · 2012: 1
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cerebrovascular Diseases (publishedVersion)
- PubMed (publishedVersion)
- Use Siena air (University of Siena) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- asymmetric dimethylarginine, L-arginine, CADASIL, endothelial dysfunction, cerebral small vessel disease, white matter lesions, plasma biomarkers, T2 lesion volume, L-arginine/ADMA ratio
- MeSH terms
- Receptor, Notch3, Adult, Antihypertensive Agents, Arginine, Brain, Chromatography, High Pressure Liquid, Endothelium, Vascular, Female, Humans, Hypertension, Lipids, Magnetic Resonance Imaging, Male, Middle Aged, Risk Factors, Biomarkers, CADASIL, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.